Windward Bio closes $201M IPO, $50M Sanofi placement
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Windward Bio Group AG (WWB) closed its initial public offering on November 16, 2026, comprising 11,838,234 common shares at $17.00 per share for an aggregate offering amount of $201.2 million. The total included the underwriters’ full option to purchase 1,544,117 additional common shares.
On the same day, the company closed a private placement to Sanofi Foreign Participations B.V. of 1,532,691 common shares and pre-funded warrants to purchase 1,408,485 common shares, in each case at $17.00 per share, for an aggregate purchase price of $50.0 million. The company’s amended and restated articles of association became effective November 14, 2026, in connection with the IPO.
Key Figures
Key Terms
pre-funded warrants financial
underwriters’ option financial
amended and restated articles of association regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did WWB’s private placement to Sanofi include?
AI-generated analysis. How Rhea-AI works. Not financial advice.